Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1972 2
1973 1
1974 3
1975 1
1977 3
1978 4
1979 3
1980 1
1981 2
1982 4
1983 4
1984 3
1985 3
1986 4
1987 7
1988 6
1989 5
1990 17
1991 11
1992 18
1993 8
1994 11
1995 14
1996 13
1997 22
1998 31
1999 24
2000 19
2001 13
2002 27
2003 25
2004 33
2005 28
2006 34
2007 37
2008 64
2009 31
2010 42
2011 53
2012 68
2013 75
2014 70
2015 92
2016 75
2017 86
2018 84
2019 77
2020 88
2021 100
2022 87
2023 75
2024 31

Text availability

Article attribute

Article type

Publication date

Search Results

1,444 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Systemic lupus erythematosus 17"
Page 1
Global epidemiology of systemic lupus erythematosus.
Barber MRW, Drenkard C, Falasinnu T, Hoi A, Mak A, Kow NY, Svenungsson E, Peterson J, Clarke AE, Ramsey-Goldman R. Barber MRW, et al. Nat Rev Rheumatol. 2021 Sep;17(9):515-532. doi: 10.1038/s41584-021-00668-1. Epub 2021 Aug 3. Nat Rev Rheumatol. 2021. PMID: 34345022 Free PMC article. Review.
Systemic lupus erythematosus (SLE) is an autoimmune disease with protean manifestations that predominantly affects young women. ...
Systemic lupus erythematosus (SLE) is an autoimmune disease with protean manifestations that predominantly affects youn …
Systemic lupus erythematosus.
Pearce L. Pearce L. Nurs Stand. 2016 Jun 22;30(43):17. doi: 10.7748/ns.30.43.17.s21. Nurs Stand. 2016. PMID: 27332581
Essential facts Systemic lupus erythematosus (SLE) is a rare, chronic autoimmune disease that causes inflammation in various parts of the body. ...Although there is no cure, early diagnosis and appropriate treatment can help to control the symptoms, preventin …
Essential facts Systemic lupus erythematosus (SLE) is a rare, chronic autoimmune disease that causes inflammation in va …
Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial.
Cohen H, Hunt BJ, Efthymiou M, Arachchillage DR, Mackie IJ, Clawson S, Sylvestre Y, Machin SJ, Bertolaccini ML, Ruiz-Castellano M, Muirhead N, Doré CJ, Khamashta M, Isenberg DA; RAPS trial investigators. Cohen H, et al. Lancet Haematol. 2016 Sep;3(9):e426-36. doi: 10.1016/S2352-3026(16)30079-5. Lancet Haematol. 2016. PMID: 27570089 Free PMC article. Clinical Trial.
Randomisation was done centrally, stratified by centre and patient type (with vs without systemic lupus erythematosus). The primary outcome was percentage change in endogenous thrombin potential (ETP) from randomisation to day 42, with non-inferiority set at …
Randomisation was done centrally, stratified by centre and patient type (with vs without systemic lupus erythematosus). …
Biomarkers for childhood-onset systemic lupus erythematosus.
Abulaban KM, Brunner HI. Abulaban KM, et al. Curr Rheumatol Rep. 2015 Jan;17(1):471. doi: 10.1007/s11926-014-0471-2. Curr Rheumatol Rep. 2015. PMID: 25475594 Free PMC article. Review.
Childhood-onset systemic lupus erythematosus (cSLE) is a systemic autoimmune disease characterized by the presence of autoantibodies. cSLE often affects multiple organs in the body and is known to have a poorer prognosis than adult-onset disease …
Childhood-onset systemic lupus erythematosus (cSLE) is a systemic autoimmune disease characterized by the presen …
Long-Term Cardiovascular Outcomes in Systemic Lupus Erythematosus.
Yafasova A, Fosbøl EL, Schou M, Baslund B, Faurschou M, Docherty KF, Jhund PS, McMurray JJV, Sun G, Kristensen SL, Torp-Pedersen C, Køber L, Butt JH. Yafasova A, et al. J Am Coll Cardiol. 2021 Apr 13;77(14):1717-1727. doi: 10.1016/j.jacc.2021.02.029. J Am Coll Cardiol. 2021. PMID: 33832598 Free article.
BACKGROUND: Data on long-term cardiovascular outcomes in systemic lupus erythematosus (SLE) are sparse. OBJECTIVES: This study sought to examine the long-term risk and prognosis associated with cardiovascular outcomes, including heart failure (HF), in …
BACKGROUND: Data on long-term cardiovascular outcomes in systemic lupus erythematosus (SLE) are sparse. OBJECTIVES: Thi …
Management of Severe Refractory Systemic Lupus Erythematosus: Real-World Experience and Literature Review.
Yang H, Liu H, Zhou Z, Zhao L, Fei Y, Chen H, Zhang F, Zhang X. Yang H, et al. Clin Rev Allergy Immunol. 2021 Feb;60(1):17-30. doi: 10.1007/s12016-020-08817-2. Epub 2020 Nov 7. Clin Rev Allergy Immunol. 2021. PMID: 33159635 Review.
Systemic lupus erythematosus (SLE) is a highly heterogeneous disease affecting multiple organs and is characterized by an aberrant immune response. ...Additionally, SLE patients with specific comorbidities and detrimental complications could lead to a clinica …
Systemic lupus erythematosus (SLE) is a highly heterogeneous disease affecting multiple organs and is characterized by …
Incidence and risk factors of tuberculosis in systemic lupus erythematosus patients: a multi-center prospective cohort study.
Zhang L, Zou X, Jiang N, Xie L, Liu J, Yang Z, Cao Q, Li C, Sun X, Zhang F, Zhao Y, Zeng X, Shi X, Liu X; ETHERTB study team. Zhang L, et al. Front Immunol. 2023 Jun 14;14:1157157. doi: 10.3389/fimmu.2023.1157157. eCollection 2023. Front Immunol. 2023. PMID: 37388724 Free PMC article.
OBJECTIVES: Both burdens of tuberculosis (TB) and systemic lupus erythematosus (SLE) in China are ranked as top three in the world. ...
OBJECTIVES: Both burdens of tuberculosis (TB) and systemic lupus erythematosus (SLE) in China are ranked as top three i …
Development of systemic lupus erythematosus in patients with immune thrombocytopenic purpura: A systematic meta-analysis.
Pamuk ON, Ali SM, Hasni S. Pamuk ON, et al. Autoimmun Rev. 2023 Apr;22(4):103297. doi: 10.1016/j.autrev.2023.103297. Epub 2023 Feb 11. Autoimmun Rev. 2023. PMID: 36781038 Free PMC article.
BACKGROUND: Recent population-based cohort studies suggest that the incidence of systemic lupus erythematosus (SLE) is increased in patients with immune thrombocytopenic purpura (ITP). ...
BACKGROUND: Recent population-based cohort studies suggest that the incidence of systemic lupus erythematosus (SLE) is …
Lupus: improving long-term prognosis.
Doria A, Briani C. Doria A, et al. Lupus. 2008 Mar;17(3):166-70. doi: 10.1177/0961203307087612. Lupus. 2008. PMID: 18372355 Review.
Over recent decades short- and medium-term survival has greatly improved in patients affected with systemic lupus erythematosus, but long-term prognosis still remains poor mainly due to complications of the disease and/or its treatment. ...However, in …
Over recent decades short- and medium-term survival has greatly improved in patients affected with systemic lupus erythemat …
Pulmonary arterial hypertension in systemic lupus erythematosus: current status and future direction.
Dhala A. Dhala A. Clin Dev Immunol. 2012;2012:854941. doi: 10.1155/2012/854941. Epub 2012 Mar 22. Clin Dev Immunol. 2012. PMID: 22489252 Free PMC article. Review.
Pulmonary arterial hypertension (PAH) is commonly associated with connective tissue diseases (CTDs) including systemic sclerosis and systemic lupus erythematosus (SLE). The prevalence of PAH in SLE is estimated to be 0.5% to 17.5%. ...Immune and inflam …
Pulmonary arterial hypertension (PAH) is commonly associated with connective tissue diseases (CTDs) including systemic sclerosis and …
1,444 results